查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2104523

靜脈輸液（IV）治療及靜脈通路市場：依產品類型、應用、最終用戶、國家及地區分類－全球產業分析、市場規模、市場佔有率及2026年至2033年預測

Intravenous (IV) Therapy and Vein Access Market, By Product Type, By Application, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 381 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025年，靜脈輸液（IV）療法和靜脈通路市場價值為136.28億美元，預計從2026年到2033年將以6.8%的複合年成長率成長。

靜脈輸液和靜脈通路市場涵蓋多種產品，例如靜脈導管、皮下注射針、植入式輸液港和輸液幫浦。這些醫療設備用於透過插入靜脈的靜脈輸液管或導管，安全地將治療藥物、液體、血液製品、生物製藥和腸外營養液輸送到患者的血液中。此市場細分涵蓋各種醫療機構，包括醫院、門診手術中心、癌症治療中心、急診室和居家照護環境。慢性病發病率的上升、外科手術數量的增加以及輸液療法的廣泛應用是推動市場成長的主要因素。美國疾病管制與預防中心 (CDC) 已將預防導管相關血流感染 (CLABSI) 列為 2025 年的關鍵公共衛生優先事項之一，因此需要進一步關注開發有效的靜脈通路裝置、感染控制技術和更安全的輸液操作規範，以預防感染。

靜脈輸液（IV）治療與靜脈通路市場－市場動態

慢性疾病負擔日益加重，推動了長期靜脈輸液治療的需求。

長期靜脈輸液治療對於癌症、腎臟病、胃腸道疾病、自體免疫疾病和嚴重感染疾病等慢性疾病的治療至關重要。隨著治療慢性病和危及生命的疾病對長期治療的需求日益成長，人們越來越需要改進、安全、便捷的靜脈通路解決方案，以便高效地向需要長期靜脈治療的患者輸送藥物、血液、營養素和療法。因此，醫院和診所正在採用更安全、更易用的植入式輸液港、中央靜脈導管和智慧輸液裝置，以支持這些療法的持續輸注。根據國際癌症研究機構 (IARC) 預測，到 2025 年，全球將新增超過 2,000 萬例癌症病例，這將進一步增加對可靠的靜脈通路裝置的需求，以支持腫瘤科和其他慢性病治療中的長期靜脈輸液治療。

靜脈輸液（IV）治療與靜脈通路市場－市場區隔分析：

全球靜脈輸液（IV）療法和靜脈通路市場按產品類型、應用、最終用戶和地區進行細分。

靜脈導管是靜脈輸液和靜脈通路市場中最大的產品類別，廣泛應用於醫院、急診、手術中心和門診機構，用於藥物輸注和液體管理。皮下注射針在注射操作、診斷應用和常規治療方面仍然保持著強勁的需求。同時，植入式輸液港越來越受歡迎，尤其是在接受反覆化療和生物製藥療法的癌症患者中，以滿足長期治療的需求。隨著智慧型藥物輸送系統的引入，輸液幫浦的需求也不斷增加。根據世界衛生組織統計，全球每年進行數十億次注射，凸顯了對可靠靜脈通路裝置的持續需求。

對於抗生素、生物製藥、化療藥物和急救藥物而言，靜脈注射的優點——吸收迅速、劑量可控、療效更佳——使其成為靜脈輸液和靜脈通路市場的主要應用領域。血液製品、腸外營養液和液體復甦療法也顯著推動了市場需求，尤其是在創傷護理、加護病房以及需要即時液體和營養支持的外科手術中。慢性病盛行率的不斷上升和醫療程序的日益複雜化正在加速先進靜脈注射系統的應用。根據國際癌症研究機構（IARC）預測，到2025年，全球將新增超過2,000萬例癌症病例，將進一步增加對可靠的液體和血管通路解決方案的需求。

靜脈輸液治療和靜脈通路市場—區域分析

北美市場憑藉其先進的技術基礎設施和健全的醫療保健政策而實力雄厚。先進的數位化互聯醫療設備（例如輸液管理系統）的快速普及，以及智慧互聯醫療網路的構建，正在推動美國靜脈輸液和靜脈通路市場的成長，其中智慧血管通路產品市場的領先企業佔據主導地位。外科手術量的增加、家庭輸液治療的興起以及慢性病盛行率的上升，都促進了美國市場的擴張。根據美國醫院協會統計，美國擁有超過6100家醫院，這意味著對靜脈導管、植入式輸液港和輸液幫浦等基本醫療設備有著強勁且持續的需求。慢性病盛行率的上升和家庭輸液治療的普及，進一步推動了市場擴張，因為這些因素增加了對先進靜脈通路設備的需求。

亞太地區的靜脈輸液和靜脈通路市場預計將在預測期內快速成長，其主要促進因素包括醫療保健服務的增加、醫療設施的擴建、外科手術數量的上升，以及先進靜脈通路裝置、輸液泵和互聯系統等醫療技術的進步。世界衛生組織指出，由於人口老化和非傳染性疾病負擔的加重，亞太地區對醫療保健服務的需求將在2025年以後持續成長。此外，隨著中國、印度、韓國和日本等新興經濟體新建專科醫院，以及家庭輸液的普及，預計先進靜脈通路裝置在各類病患治療中的應用將更加廣泛。

目錄

第1章：靜脈輸液（IV）療法和靜脈通路市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章 靜脈輸液和靜脈通路的主要市場趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章：靜脈輸液療法與靜脈通路產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景展望圖
  • 管理體制分析

第5章 靜脈輸液治療與靜脈通路市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：靜脈輸液治療與靜脈通路市場趨勢

  • 2025年靜脈輸液（IV）療法及靜脈通路市佔率分析
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章 靜脈輸液（IV）治療及靜脈通路市場：依產品類型分類

  • 概述
    • 基於細分市場的市場佔有率分析：按產品類型
    • 皮下注射針
    • 嵌入式連接埠
    • 點滴幫浦
    • 靜脈導管
    • 其他

第8章 靜脈輸液（IV）治療與靜脈通路市場：依應用領域分類

  • 概述
    • 基於細分市場的市場佔有率分析：按應用領域
    • 血液製品
    • 營養補充品和緩衝劑
    • 藥物管理
    • 血液容量替代療法
    • 其他

第9章 靜脈輸液（IV）治療與靜脈通路市場：依最終使用者分類

  • 概述
    • 基於細分市場的市場佔有率分析：按最終用戶分類
    • 門診手術中心
    • 醫院
    • 診所
    • 其他

第10章 靜脈輸液治療與靜脈通路市場：依地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商：歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 丹麥
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商：亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 台灣
    • 越南
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商：中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 伊朗
    • 卡達
    • 其他中東和非洲國家

第11章 主要供應商分析：靜脈輸液（IV）治療與靜脈通路產業

  • 競爭基準
    • 競爭對手儀錶板
    • 競爭定位
  • 公司簡介
    • Access Vascular, Inc.
    • AngioDynamics, Inc.
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Becton, Dickinson and Company（BD）
    • Cardinal Health, Inc.
    • Cook Medical
    • Edwards Lifesciences Corporation
    • Fresenius Kabi AG
    • ICU Medical, Inc.
    • Medtronic plc
    • Nipro Corporation
    • Poly Medicure Ltd.
    • Teleflex Incorporated
    • Terumo Corporation
    • Vygon SAS
    • Others

第12章：AnalystView 的全景視圖

簡介目錄
Product Code: ANV7079

Intravenous (IV) Therapy and Vein Access Market size was valued at US$ 13,602.8 Million in 2025, expanding at a CAGR of 6.8% from 2026 to 2033.

The IV Therapy and Vein Access Market includes various types of products, such as IV catheters, hypodermic needles, implantable ports, and infusion pumps. These devices are used to safely deliver therapeutics, fluids, blood products, biologics, and parenteral nutrition into patients' bloodstreams through an IV line or catheter inserted into a vein. This market segment spans several medical environments, including hospitals, outpatient surgery centers, oncology centers, emergency rooms, and in-home care settings. The increasing incidence of chronic diseases, the rising number of surgeries, and the increased use of infusion therapy are the key drivers of market growth. The prevention of CLABSI has been stated by the CDC to be one of their significant public health priorities for 2025, and increased attention is needed toward the development of effective vascular access devices, infection control technology, and safer infusion practices to prevent infections.

Intravenous (IV) Therapy and Vein Access Market- Market Dynamics

Rising Burden of Chronic Diseases Driving Demand for Long-Term Intravenous Therapy

Prolonged infusion therapy is crucial for managing chronic diseases such as cancer, kidney disease, gastrointestinal disorders, autoimmune diseases, and critical infections. The increasing demand for prolonged therapies to treat chronic and life-threatening diseases has stimulated the need for improved, safe, and convenient venous access solutions to efficiently deliver medications, blood, nutrients, and therapies to patients suffering from conditions requiring extended periods of intravenous treatment. As a consequence, hospitals and clinics are adopting implantable ports, central venous catheters, and smart infusion devices with increased safety features and improved ease of use to support the sustained use of such treatments. In 2025, according to the IARC (International Agency for Research on Cancer), more than 20 million new cases of cancer were registered globally, reinforcing the growing need for reliable vascular access devices to support long-term infusion therapies across oncology and other chronic care settings.

Intravenous (IV) Therapy and Vein Access Market- Segmentation Analysis:

The Global Intravenous (IV) Therapy and Vein Access Market is segmented on the basis of Product Type, Application, End User, and Region.

Intravenous catheters represent the largest product segment in the IV Therapy and Vein Access Market due to their extensive use across hospitals, emergency departments, surgical centers, and outpatient facilities for medication delivery and fluid management. Hypodermic needles continue to maintain strong demand across injection procedures, diagnostic applications, and routine therapeutic treatments. Meanwhile, implantable ports are gaining adoption for long-term treatment requirements, particularly among oncology patients undergoing repeated chemotherapy and biologic therapies. Infusion pumps are also experiencing increased demand with the integration of smart medication delivery systems. According to the WHO, billions of injections are administered globally every year, supporting the continued need for reliable vascular access devices.

Medication administration remains the leading application segment in the IV Therapy and Vein Access Market due to the advantages of intravenous delivery, including rapid absorption, controlled dosing, and improved therapeutic effectiveness for antibiotics, biologics, chemotherapy agents, and emergency medications. Blood products, parenteral nutrition solutions, and volume replacement therapies are also contributing significantly to market demand, particularly in trauma care, intensive care units, and surgical procedures requiring immediate fluid or nutrient support. The rising prevalence of chronic diseases and increasing complexity of medical treatments are accelerating the adoption of advanced IV systems. According to IARC, more than 20 million new cancer cases were reported globally in 2025, further increasing demand for dependable infusion and vascular access solutions.

Intravenous (IV) Therapy and Vein Access Market- Geographical Insights

North America's market position is amplified by its technologically advanced infrastructure and robust healthcare policies. A smart and interlinked healthcare network, coupled with the rapid adoption of sophisticated digitally interconnected medical devices such as infusion management systems, is fueling the growth of the U.S. IV Therapy and Vein Access Market, led by market players that operate in the smart vascular access product market. Increases in the number of surgical procedures, at-home infusion, and chronic diseases are contributing to market expansion in the U.S. According to the American Hospital Association, more than 6,100 hospitals are present in the U.S., and that directly translates to substantial and unwavering demand for essential medical devices such as intravenous catheters, implantable ports, and infusion pumps. With the increasing prevalence of chronic diseases and the expansion of at-home infusion therapy, the market is further expanding with a need for advanced IV access devices.

Asia-Pacific market for IV Therapy and Vein Access is expected to experience a fast-growing pace over the forecast period due to increasing healthcare services, the expansion of healthcare facilities, and growing rates of surgeries, along with advancements in medical technology such as cutting-edge IV access devices, infusion pumps, and connected systems. According to the WHO, the Asia-Pacific region is witnessing growth in demand for healthcare services since 2025 with a rising aging population and a growing burden of non-communicable diseases in the region. Moreover, developing economies such as China, India, South Korea, and Japan are also seeing the establishment of new specialty hospitals, which will expand the use of advanced IV devices for various patient treatments, along with the widespread adoption of at-home infusions.

Intravenous (IV) Therapy and Vein Access Market- Competitive Landscape:

The Intravenous (IV) Therapy and Vein Access Market is characterized by intense competition among numerous players, who are strategically focused on introducing innovative product offerings and enhancing their market presence through product development, technological advancements, and the expansion of product portfolios to cater to specific needs of patient care, such as digital infusion pumps, smart venous access devices, antimicrobial catheters, and connected healthcare solutions. Regulatory approvals, strategic partnerships, mergers and acquisitions, and new product launches are some of the strategies that have helped companies increase their market share. Current investment areas include the development of advanced medical technology, such as smart IV devices and remote patient monitoring.

Recent Developments:

In February 2025, BD expanded its connected medication management portfolio by enhancing interoperability between its BD Alaris(TM) Infusion System and hospital digital platforms, enabling improved medication administration workflows and clinical decision support.

In April 2025, ICU Medical introduced additional enhancements across its infusion therapy portfolio, including updated software capabilities for the Plum Duo(TM) Infusion Pump, designed to improve clinical workflow, interoperability, and medication safety while supporting healthcare providers in high-acuity environments.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INTRAVENOUS (IV) THERAPY AND VEIN ACCESS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Access Vascular, Inc.
  • AngioDynamics, Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company (BD)
  • Cardinal Health, Inc.
  • Cook Medical
  • Edwards Lifesciences Corporation
  • Fresenius Kabi AG
  • ICU Medical, Inc.
  • Medtronic plc
  • Nipro Corporation
  • Poly Medicure Ltd.
  • Teleflex Incorporated
  • Terumo Corporation
  • Vygon SAS
  • Others

GLOBAL INTRAVENOUS (IV) THERAPY AND VEIN ACCESS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020 - 2033

  • Hypodermic Needles
  • Implantable Ports
  • Infusion Pumps
  • Intravenous Catheters
  • Others

GLOBAL INTRAVENOUS (IV) THERAPY AND VEIN ACCESS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Blood Based Products
  • Nutrition And Buffer Solution
  • Medication Administration
  • Volume Expander
  • Others

GLOBAL INTRAVENOUS (IV) THERAPY AND VEIN ACCESS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

  • Ambulatory Surgical Center
  • Hospitals
  • Clinics
  • Others

GLOBAL INTRAVENOUS (IV) THERAPY AND VEIN ACCESS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. IV Therapy and Vein Access Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
  • 2.2. Competitive Insights

3. IV Therapy and Vein Access Key Market Trends

  • 3.1. IV Therapy and Vein Access Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. IV Therapy and Vein Access Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. IV Therapy and Vein Access Market Opportunities
  • 3.4. IV Therapy and Vein Access Market Future Trends

4. IV Therapy and Vein Access Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. IV Therapy and Vein Access Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. IV Therapy and Vein Access Market Landscape

  • 6.1. IV Therapy and Vein Access Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. IV Therapy and Vein Access Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2025 & 2033 (%)
    • 7.1.2. Hypodermic Needles
    • 7.1.3. Implantable Ports
    • 7.1.4. Infusion Pumps
    • 7.1.5. Intravenous Catheters
    • 7.1.6. Other

8. IV Therapy and Vein Access Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 8.1.2. Blood Based Products
    • 8.1.3. Nutrition And Buffer Solution
    • 8.1.4. Medication Administration
    • 8.1.5. Volume Expander
    • 8.1.6. Others

9. IV Therapy and Vein Access Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
    • 9.1.2. Ambulatory Surgical Center
    • 9.1.3. Hospitals
    • 9.1.4. Clinics
    • 9.1.5. Others

10. IV Therapy and Vein Access Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. IV Therapy and Vein Access Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. IV Therapy and Vein Access Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.16. Denmark
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.16.3. Denmark Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.16.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.16.5. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.17. Rest of Europe
      • 10.3.17.1. Overview
      • 10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.17.5. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. IV Therapy and Vein Access Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.15. Taiwan
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.15.3. Taiwan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.15.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.15.5. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.16. Vietnam
      • 10.4.16.1. Overview
      • 10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.16.3. Vietnam Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.16.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.16.5. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.17. Rest of APAC
      • 10.4.17.1. Overview
      • 10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.17.5. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. IV Therapy and Vein Access Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. IV Therapy and Vein Access Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.13. Iran
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.13.3. Iran Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.13.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.13.5. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.14. Qatar
      • 10.6.14.1. Overview
      • 10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.14.3. Qatar Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.14.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.14.5. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.15. Rest of MEA
      • 10.6.15.1. Overview
      • 10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.15.5. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

11. Key Vendor Analysis- IV Therapy and Vein Access Industry

  • 11.1. Competitive Benchmarking
    • 11.1.1. Competitive Dashboard
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Access Vascular, Inc.
    • 11.2.2. AngioDynamics, Inc.
    • 11.2.3. B. Braun Melsungen AG
    • 11.2.4. Baxter International Inc.
    • 11.2.5. Becton, Dickinson and Company (BD)
    • 11.2.6. Cardinal Health, Inc.
    • 11.2.7. Cook Medical
    • 11.2.8. Edwards Lifesciences Corporation
    • 11.2.9. Fresenius Kabi AG
    • 11.2.10. ICU Medical, Inc.
    • 11.2.11. Medtronic plc
    • 11.2.12. Nipro Corporation
    • 11.2.13. Poly Medicure Ltd.
    • 11.2.14. Teleflex Incorporated
    • 11.2.15. Terumo Corporation
    • 11.2.16. Vygon SAS
    • 11.2.17. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us